Orchestra BioMed Holdings, Inc. Earnings Per Share (Diluted)
Orchestra BioMed Holdings, Inc. (OBIO) reported Earnings Per Share (Diluted) of -$0.38 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.38.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.33.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.10.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.40.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for fiscal 2025 was -$1.11.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for fiscal 2024 was -$1.66.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for fiscal 2023 was -$1.48.
- Orchestra BioMed Holdings, Inc. earnings per share, diluted for fiscal 2022 was -$2.24.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.38 10-Q · filed 2026-08-10 | -$0.72 10-Q · filed 2026-08-10 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2026-03-31 | -$0.33 10-Q · filed 2026-05-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.11 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-10 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.37 10-Q · filed 2025-11-10 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-06-30 | -$0.50 10-Q · filed 2026-08-10 | -$0.99 10-Q · filed 2026-08-10 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-03-31 | -$0.49 10-Q · filed 2026-05-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2024-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$1.28 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$1.66 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$0.41 10-Q · filed 2025-11-10 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.23 10-Q · filed 2025-11-10 | -$1.60 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||||
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-12 | -$0.82 10-Q · filed 2025-08-12 | -$1.19 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.57 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||||
| 2024-03-31 | -$0.38 10-Q · filed 2025-05-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.12 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.47 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||||
| 2023-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.48 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.38 10-Q · filed 2024-11-12 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.11 10-Q · filed 2024-11-12 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.35 10-Q · filed 2024-08-12 | -$0.74 10-Q · filed 2024-08-12 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.68 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2022-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$2.24 10-K · filed 2024-03-27 | -$0.17 10-K · filed 2023-01-25 | |||
| 2022-09-30 | -$0.51 10-Q · filed 2023-11-13 | -$0.05 10-Q · filed 2022-11-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.80 10-Q · filed 2023-11-13 | -$0.10 10-Q · filed 2022-11-14 | -$1.60 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||
| 2022-06-30 | -$0.77 10-Q · filed 2023-08-10 | -$0.04 10-Q · filed 2022-08-15 | -$0.74 10-Q · filed 2023-08-10 | -$0.06 10-Q · filed 2022-08-15 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||
| 2022-03-31 | -$0.62 10-Q · filed 2023-05-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2021-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-01-25 | -$0.01 derived: net income ÷ weighted average shares · filed 2023-01-25 | -$0.01 derived: net income ÷ weighted average shares · filed 2023-01-25 | -$0.02 10-K · filed 2023-01-25 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.01 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | -$0.01 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |